Iridium Corporation (46K)
XHAN 
Summary
46K Chart
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
iRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.
IRADIMED CORPORATION (IRMD) Q3 2025 Earnings Call Transcript
IRADIMED CORPORATION ( IRMD ) Q3 2025 Earnings Call November 3, 2025 11:00 AM EST Company Participants Roger Susi - Founder, Chairman, CEO & President John Glenn - CFO & Corporate Secretary Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Kyle Bauser - ROTH Capital Partners, LLC, Research Division Presentation Operator Welcome to the IRADIMED CORPORATION Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded today, November 3, 2025, and contains time-sensitive accurate information that is valid only for today.
Iridium Corporation (46K) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Iridium Corporation ever had a stock split?
Iridium Corporation Profile
| Independent Power and Renewable Electricity Producers Industry | Utilities Sector | Roger E. Susi CEO | XHAN Exchange | US46266A1097 ISIN |
| US Country | 160 Employees | 29 May 2026 Last Dividend | - Last Split | 16 Jul 2014 IPO Date |
Overview
IRADIMED CORPORATION is a leader in the development, manufacturing, marketing, and distribution of magnetic resonance imaging (MRI) compatible medical devices along with related accessories, disposables, and services on a global scale. Established in 1992, the company has carved a niche in MRI safety, providing solutions that enable patient care without compromising on the quality of diagnostic imaging. It operates mainly within the United States but has a significant international presence. The headquarters of IRADIMED CORPORATION is in Winter Springs, Florida. The company primarily caters to hospitals, acute care facilities, and outpatient imaging centers, distributing its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors.
Products and Services
- MRidium MRI Compatible Intravenous (IV) Infusion Pump System
This advanced infusion pump system is designed to safely administer IV fluids and medications within the MRI suite, mitigating the risk of magnetic interference with the imaging process. The MRidium system comes with specialized disposable IV tubing sets to ensure compatibility and safety.
- MRI Compatible Patient Vital Signs Monitoring System
A comprehensive solution for monitoring vital signs of patients undergoing MRI scans, this system ensures that healthcare professionals can maintain continuous observation of patient physiological parameters without interfering with the MRI machine's operations.
- 3600 FMD1 with RALU Ferromagnetic Detection Device
The 3600 FMD1 with RALU is designed to enhance safety in MRI environments by detecting and alerting staff to the presence of ferromagnetic objects before they enter the MRI room. This helps prevent accidents and injuries resulting from objects being attracted to the magnet.
- Non-magnetic IV Poles, Wireless Remote Displays/Controls, Side Car Pump Modules, Dose Error Reduction Systems
IRADIMED CORPORATION also offers a range of accessories designed to complement and enhance the functionality of its MRI compatible devices. These include non-magnetic IV poles for safe use in MRI suites, wireless remote displays/controls for easier operation, side car pump modules for expanded infusion capabilities, and dose error reduction systems to enhance patient safety by minimizing medication errors.
- SpO2 Monitoring with Sensors and Accessories
This product allows for the continuous monitoring of blood oxygen saturation (SpO2) levels in patients within the MRI suite, using specially designed sensors and accessories that are immune to magnetic interference, ensuring accurate and reliable readings even during scanning.
